Phosphocreatine as a possible modulator of the adenylate pool.
Ronca
G
G
Institute of Biological Chemistry, Faculty of Medicine, Pisa, Italy.
Pezzini
A
A
Conte
A
A
Galbani
P
P
Zucchi
R
R
Ronca-Testoni
S
S
D000227:Adenine Nucleotides / Q000032:analysis* / Q000378:metabolism; D000284:Administration, Oral; D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects*; D003401:Creatine / Q000032:analysis / Q000097:blood* / Q000494:pharmacology; D005260:Female; D006801:Humans; D009132:Muscles / Q000032:analysis*; D009206:Myocardium / Q000032:analysis*; D010725:Phosphocreatine / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors; D014407:Tumor Cells, Cultured / Q000032:analysis / Q000187:drug effects
D000227:Adenine Nucleotides; D010725:Phosphocreatine; D003401:Creatine